IGF1 and hyperinsulinemic hypoglycemia, familial, 4: Exogenous administration of IGF-I in conditions without IGF-I deficiency, usually responds to an attempt to exploit its anti-inflammatory, hematopoietic, antioxidant, metabolic or anabolic properties.